Suchergebnisse - "Cochat, Pierre"

PubPharm (206)

1

Composite event-free-survival as an endpoint in oncology drug evaluation : Review and guidance perspectives from the Haute Autorité de Santé (HAS)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Lengliné, E. | Baba, J. | de Boissieu, P. | +5

2

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

enthalten in: BMJ evidence-based medicine | 2024

von Vanier, A. | Fernandez, J. | Kelley, S. | +18

3

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1 : Findings of the European Hyperoxaluria Consortium

enthalten in: Kidney international reports | 2023

von Metry, E. | Garrelfs, S. | Deesker, L. | +23

CommentIn: Kidney Int Rep. 2023 Sep 07;8(11):2187-2190. - PMID 38025235

4

The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies

enthalten in: Kidney international | 2023

von Petzold, F. | Billot, K. | Chen, X. | +120

5

Clinical and molecular characterization of a large primary hyperoxaluria cohort from Saudi Arabia : a retrospective study

enthalten in: Pediatric nephrology (Berlin, Germany) | 2023

von Alfadhel, M. | Umair, M. | Alghamdi, M. | +8

6

Revolution in the field of primary and secondary hyperoxalurias : Stay tuned!

enthalten in: Medecine sciences : M/S | 2023

von Bacchetta, J. | Cochat, P.

7

PHYOX2 : a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2

enthalten in: Kidney international | 2023

von Baum, M. | Langman, C. | Cochat, P. | +20

CommentIn: J Urol. 2023 Feb;209(2):440-442. - PMID 36349574

8

Improved Outcome of Infantile Oxalosis Over Time in Europe : Data From the OxalEurope Registry

enthalten in: Kidney international reports | 2022

von Deesker, L. | Garrelfs, S. | Mandrile, G. | +15

9

Phase 3 trial of lumasiran for primary hyperoxaluria type 1 : A new RNAi therapeutic in infants and young children

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2022

von Sas, D. | Magen, D. | Hayes, W. | +43

10

Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

enthalten in: Kidney international | 2022

von Hoppe, B. | Koch, A. | Cochat, P. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]